<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31395804</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>16</Issue><PubDate><Year>2019</Year><Month>Aug</Month><Day>09</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>CD34 Identifies a Subset of Proliferating Microglial Cells Associated with Degenerating Motor Neurons in ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3880</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms20163880</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is characterized by degeneration of upper and lower motor neurons accompanied by proliferation of reactive microglia in affected regions. However, it is unknown whether the hematopoietic marker CD34 can identify a subpopulation of proliferating microglial cells in the ALS degenerating spinal cord. Immunohistochemistry for CD34 and microglia markers was performed in lumbar spinal cords of ALS rats bearing the SOD1<sup>G93A</sup> mutation and autopsied ALS and control human subjects. Characterization of CD34-positive cells was also performed in primary cell cultures of the rat spinal cords. CD34 was expressed in a large number of cells that closely interacted with degenerating lumbar spinal cord motor neurons in symptomatic SOD1<sup>G93A</sup> rats, but not in controls. Most CD34<sup>+</sup> cells co-expressed the myeloid marker CD11b, while only a subpopulation was stained for Iba1 or CD68. Notably, CD34<sup>+</sup> cells actively proliferated and formed clusters adjacent to damaged motor neurons bearing misfolded SOD1. CD34<sup>+</sup> cells were identified in the proximity of motor neurons in autopsied spinal cord from sporadic ALS subjects but not in controls. Cell culture of symptomatic SOD1<sup>G93A</sup> rat spinal cords yielded a large number of CD34<sup>+</sup> cells exclusively in the non-adherent phase, which generated microglia after successive passaging. A yet unrecognized CD34<sup>+</sup> cells, expressing or not the microglial marker Iba1, proliferate and accumulate adjacent to degenerating spinal motor neurons, representing an intriguing cell target for approaching ALS pathogenesis and therapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kovacs</LastName><ForeName>Mari&#xe1;ngeles</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, Montevideo 11400, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trias</LastName><ForeName>Emiliano</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, Montevideo 11400, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varela</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, Montevideo 11400, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibarburu</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, Montevideo 11400, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beckman</LastName><ForeName>Joseph S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Linus Pauling Institute, Department of Biochemistry and Biophysics, Environmental Health Sciences Center, Oregon State University, Corvallis, OR 97331, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moura</LastName><ForeName>Ivan C</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Imagine Institute, H&#xf4;pital Necker, 75015 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, 75015 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Descartes-Sorbonne Paris Cit&#xe9; University, Imagine Institute, 75006 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNRS ERL 8254, INSERM U1163, Universit&#xe9; Paris Descartes, 75006 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Excellence GR-Ex, 75015 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipe Lab&#xe9;lis&#xe9;e par la Ligue Nationale contre le cancer, 75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermine</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Imagine Institute, H&#xf4;pital Necker, 75015 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, 75015 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Descartes-Sorbonne Paris Cit&#xe9; University, Imagine Institute, 75006 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CNRS ERL 8254, INSERM U1163, Universit&#xe9; Paris Descartes, 75006 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Excellence GR-Ex, 75015 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equipe Lab&#xe9;lis&#xe9;e par la Ligue Nationale contre le cancer, 75013 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AB Science, 75008 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Hematology, H&#xf4;pital Necker, 75015 Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre national de r&#xe9;f&#xe9;rence des mastocytoses (CEREMAST), 75743 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Peter H</ForeName><Initials>PH</Initials><Identifier Source="ORCID">0000-0001-9391-7464</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Yuri</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbeito</LastName><ForeName>Luis</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7187-511X</Identifier><AffiliationInfo><Affiliation>Institut Pasteur de Montevideo, Montevideo 11400, Uruguay. barbeito@pasteur.edu.uy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS111275</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS092651</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA013148</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX004419</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018952">Antigens, CD34</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018952" MajorTopicYN="N">Antigens, CD34</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017354" MajorTopicYN="N">Point Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD34</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">misfolded SOD1</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword></KeywordList><CoiStatement>Olivier Hermine is a cofounder and shareholder of AB science. Others have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31395804</ArticleId><ArticleId IdType="pmc">PMC6720880</ArticleId><ArticleId IdType="doi">10.3390/ijms20163880</ArticleId><ArticleId IdType="pii">ijms20163880</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boillee S., Vande Velde C., Cleveland D.W. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39&#x2013;59. doi: 10.1016/j.neuron.2006.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001;2:806&#x2013;819. doi: 10.1038/35097565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35097565</ArticleId><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Ibarburu S., Barreto-Nunez R., Barbeito L. Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis. Neurosci. Lett. 2017;636:27&#x2013;31. doi: 10.1016/j.neulet.2016.07.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.07.052</ArticleId><ArticleId IdType="pubmed">27473942</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Tauber C., Vercoullie J., Arlicot N., Prunier C., Praline J., Nicolas G., Venel Y., Hommet C., Baulieu J.L., et al. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e52941. doi: 10.1371/journal.pone.0052941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052941</ArticleId><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Beers D.R., Zhao W., Appel S.H. Microglia in ALS: The good, the bad, and the resting. J. Neuroimmune Pharm. 2009;4:389&#x2013;398. doi: 10.1007/s11481-009-9171-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-009-9171-5</ArticleId><ArticleId IdType="pubmed">19731042</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B., Zhao W., Beers D.R., Henkel J.S., Appel S.H. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp. Neurol. 2012;237:147&#x2013;152. doi: 10.1016/j.expneurol.2012.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2012.06.011</ArticleId><ArticleId IdType="pmc">PMC4126417</ArticleId><ArticleId IdType="pubmed">22735487</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A.E., Ferraiuolo L., Haidet-Phillips A.M., Schmelzer L., Braun L., Miranda C.J., Ladner K.J., Bevan A.K., Foust K.D., Godbout J.P., et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Diaz-Amarilla P., Olivera-Bravo S., Isasi E., Drechsel D.A., Lopez N., Bradford C.S., Ireton K.E., Beckman J.S., Barbeito L. Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS. Front. Cell. Neurosci. 2013;7:274. doi: 10.3389/fncel.2013.00274.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00274</ArticleId><ArticleId IdType="pmc">PMC3871969</ArticleId><ArticleId IdType="pubmed">24399933</ArticleId></ArticleIdList></Reference><Reference><Citation>Fendrick S.E., Xue Q.S., Streit W.J. Formation of multinucleated giant cells and microglial degeneration in rats expressing a mutant Cu/Zn superoxide dismutase gene. J. Neuroinflamm. 2007;4:9. doi: 10.1186/1742-2094-4-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-4-9</ArticleId><ArticleId IdType="pmc">PMC1808448</ArticleId><ArticleId IdType="pubmed">17328801</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) Proc. Natl. Acad. Sci. USA. 2002;99:1604&#x2013;1609. doi: 10.1073/pnas.032539299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.032539299</ArticleId><ArticleId IdType="pmc">PMC122237</ArticleId><ArticleId IdType="pubmed">11818550</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Beilby P.R., Kovacs M., Ibarburu S., Varela V., Barreto-Nunez R., Bradford S.C., Beckman J.S., Barbeito L. Emergence of Microglia Bearing Senescence Markers During Paralysis Progression in a Rat Model of Inherited ALS. Front. Aging Neurosci. 2019;11:42. doi: 10.3389/fnagi.2019.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00042</ArticleId><ArticleId IdType="pmc">PMC6403180</ArticleId><ArticleId IdType="pubmed">30873018</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Amarilla P., Olivera-Bravo S., Trias E., Cragnolini A., Martinez-Palma L., Cassina P., Beckman J., Barbeito L. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2011;108:18126&#x2013;18131. doi: 10.1073/pnas.1110689108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Palma L., Miquel E., Lagos-Rodriguez V., Barbeito L., Cassina A., Cassina P. Mitochondrial Modulation by Dichloroacetate Reduces Toxicity of Aberrant Glial Cells and Gliosis in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2019;16:203&#x2013;215. doi: 10.1007/s13311-018-0659-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-018-0659-7</ArticleId><ArticleId IdType="pmc">PMC6361051</ArticleId><ArticleId IdType="pubmed">30159850</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Ibarburu S., Barreto-Nunez R., Babdor J., Maciel T.T., Guillo M., Gros L., Dubreuil P., Diaz-Amarilla P., Cassina P., et al. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J. Neuroinflammation. 2016;13:177. doi: 10.1186/s12974-016-0620-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0620-9</ArticleId><ArticleId IdType="pmc">PMC4940876</ArticleId><ArticleId IdType="pubmed">27400786</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Muriana A., Mancuso R., Francos-Quijorna I., Olmos-Alonso A., Osta R., Perry V.H., Navarro X., Gomez-Nicola D., Lopez-Vales R. CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves. Sci. Rep. 2016;6:25663. doi: 10.1038/srep25663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25663</ArticleId><ArticleId IdType="pmc">PMC4865981</ArticleId><ArticleId IdType="pubmed">27174644</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause D.S., Ito T., Fackler M.J., Smith O.M., Collector M.I., Sharkis S.J., May W.S. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood. 1994;84:691&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pubmed">7519070</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidney L.E., Branch M.J., Dunphy S.E., Dua H.S., Hopkinson A. Concise review: Evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014;32:1380&#x2013;1389. doi: 10.1002/stem.1661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1661</ArticleId><ArticleId IdType="pmc">PMC4260088</ArticleId><ArticleId IdType="pubmed">24497003</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuSamra D.B., Aleisa F.A., Al-Amoodi A.S., Jalal Ahmed H.M., Chin C.J., Abuelela A.F., Bergam P., Sougrat R., Merzaban J.S. Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44. Blood Adv. 2017;1:2799&#x2013;2816. doi: 10.1182/bloodadvances.2017004317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2017004317</ArticleId><ArticleId IdType="pmc">PMC5745127</ArticleId><ArticleId IdType="pubmed">29296932</ArticleId></ArticleIdList></Reference><Reference><Citation>Asheuer M., Pflumio F., Benhamida S., Dubart-Kupperschmitt A., Fouquet F., Imai Y., Aubourg P., Cartier N. Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc. Natl. Acad. Sci. USA. 2004;101:3557&#x2013;3562. doi: 10.1073/pnas.0306431101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0306431101</ArticleId><ArticleId IdType="pmc">PMC373501</ArticleId><ArticleId IdType="pubmed">14990803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladeby R., Wirenfeldt M., Dalmau I., Gregersen R., Garcia-Ovejero D., Babcock A., Owens T., Finsen B. Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia. 2005;50:121&#x2013;131. doi: 10.1002/glia.20159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20159</ArticleId><ArticleId IdType="pubmed">15657941</ArticleId></ArticleIdList></Reference><Reference><Citation>Graumann U., Ritz M.F., Rivero B.G., Hausmann O. CD133 expressing pericytes and relationship to SDF-1 and CXCR4 in spinal cord injury. Curr. Neurovascular Res. 2010;7:144&#x2013;154. doi: 10.2174/156720210791184907.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720210791184907</ArticleId><ArticleId IdType="pubmed">20374199</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinze A., Stolzing A. Microglia differentiation using a culture system for the expansion of mice non-adherent bone marrow stem cells. J. Inflamm. 2012;9:12. doi: 10.1186/1476-9255-9-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-9255-9-12</ArticleId><ArticleId IdType="pmc">PMC3495406</ArticleId><ArticleId IdType="pubmed">22471998</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S., Aijo T., Vickovic S., Braine C., Kang K., Mollbrink A., Fagegaltier D., Andrusivova Z., Saarenpaa S., Saiz-Castro G., et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364:89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer P.L., McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:459&#x2013;470. doi: 10.1002/mus.10191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10191</ArticleId><ArticleId IdType="pubmed">12362410</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Toledo J.B., Van Deerlin V.M., Elman L., McCluskey L., Lee V.M., Trojanowski J.Q. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e39216. doi: 10.1371/journal.pone.0039216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039216</ArticleId><ArticleId IdType="pmc">PMC3375234</ArticleId><ArticleId IdType="pubmed">22720079</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagan A.M., Gage F.H. Mechanisms of sprouting in the adult central nervous system: Cellular responses in areas of terminal degeneration and reinnervation in the rat hippocampus. Neuroscience. 1994;58:705&#x2013;725. doi: 10.1016/0306-4522(94)90449-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(94)90449-9</ArticleId><ArticleId IdType="pubmed">8190252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladeby R., Wirenfeldt M., Garcia-Ovejero D., Fenger C., Dissing-Olesen L., Dalmau I., Finsen B. Microglial cell population dynamics in the injured adult central nervous system. Brain Res. Brain Res. Rev. 2005;48:196&#x2013;206. doi: 10.1016/j.brainresrev.2004.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2004.12.009</ArticleId><ArticleId IdType="pubmed">15850658</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan L., Krabbe G., Du F., Jones I., Reichert M.C., Telpoukhovskaia M., Kodama L., Wang C., Cho S.H., Sayed F., et al. Proximal recolonization by self-renewing microglia re-establishes microglial homeostasis in the adult mouse brain. PLoS Biol. 2019;17:e3000134. doi: 10.1371/journal.pbio.3000134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000134</ArticleId><ArticleId IdType="pmc">PMC6383943</ArticleId><ArticleId IdType="pubmed">30735499</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog. Neurobiol. 1999;57:563&#x2013;581. doi: 10.1016/S0301-0082(98)00069-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-0082(98)00069-0</ArticleId><ArticleId IdType="pubmed">10221782</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling M., Besselmann M., Leonhard C., Mueller M., Ringelstein E.B., Kiefer R. Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: A study in green fluorescent protein transgenic bone marrow chimeric mice. Exp. Neurol. 2003;183:25&#x2013;33. doi: 10.1016/S0014-4886(03)00082-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-4886(03)00082-7</ArticleId><ArticleId IdType="pubmed">12957485</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka R., Komine-Kobayashi M., Mochizuki H., Yamada M., Furuya T., Migita M., Shimada T., Mizuno Y., Urabe T. Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia. Neuroscience. 2003;117:531&#x2013;539. doi: 10.1016/S0306-4522(02)00954-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(02)00954-5</ArticleId><ArticleId IdType="pubmed">12617960</ArticleId></ArticleIdList></Reference><Reference><Citation>Davoust N., Vuaillat C., Cavillon G., Domenget C., Hatterer E., Bernard A., Dumontel C., Jurdic P., Malcus C., Confavreux C., et al. Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia. Faseb J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2006;20:2081&#x2013;2092. doi: 10.1096/fj.05-5593com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-5593com</ArticleId><ArticleId IdType="pubmed">17012260</ArticleId></ArticleIdList></Reference><Reference><Citation>Dissing-Olesen L., Ladeby R., Nielsen H.H., Toft-Hansen H., Dalmau I., Finsen B. Axonal lesion-induced microglial proliferation and microglial cluster formation in the mouse. Neuroscience. 2007;149:112&#x2013;122. doi: 10.1016/j.neuroscience.2007.06.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2007.06.037</ArticleId><ArticleId IdType="pubmed">17870248</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Siddiqui S., Gabriely G., Lanser A.J., Dake B., Murugaiyan G., Doykan C.E., Wu P.M., Gali R.R., Iyer L.K., et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Investig. 2012;122:3063&#x2013;3087. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S., Haller E., Navarro S., Besong T.E., Boccio K.J., Hailu S., Khatib M., Sanberg P.R., Appel S.H., Borlongan C.V. Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair. Exp. Neurol. 2018;310:33&#x2013;47. doi: 10.1016/j.expneurol.2018.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.08.012</ArticleId><ArticleId IdType="pmc">PMC6203661</ArticleId><ArticleId IdType="pubmed">30172620</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S., Willing A.E., Zigova T., Saporta S., Justen E.B., Lane J.C., Hudson J.E., Chen N., Davis C.D., Sanberg P.R. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: Distribution, migration, and differentiation. J. Hematother Stem Cell Res. 2003;12:255&#x2013;270. doi: 10.1089/152581603322022990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/152581603322022990</ArticleId><ArticleId IdType="pubmed">12857367</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S., Kurien C., Thomson A., Falco D., Ahmad S., Staffetti J., Steiner G., Abraham S., James G., Mahendrasah A., et al. Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair. Sci. Rep. 2017;7:884. doi: 10.1038/s41598-017-00993-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00993-0</ArticleId><ArticleId IdType="pmc">PMC5429840</ArticleId><ArticleId IdType="pubmed">28408761</ArticleId></ArticleIdList></Reference><Reference><Citation>Eve D.J., Steiner G., Mahendrasah A., Sanberg P.R., Kurien C., Thomson A., Borlongan C.V., Garbuzova-Davis S. Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier. Oncotarget. 2018;9:10621&#x2013;10634. doi: 10.18632/oncotarget.24360.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.24360</ArticleId><ArticleId IdType="pmc">PMC5828209</ArticleId><ArticleId IdType="pubmed">29535831</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K., Graffmo K., Pakkenberg B., Weber M., Nielsen M., Marklund S., Brannstrom T., Andersen P.M. Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes. J. Neurol. Neurosurg. Psychiatry. 2019;90:861&#x2013;869. doi: 10.1136/jnnp-2018-319386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319386</ArticleId><ArticleId IdType="pmc">PMC6691870</ArticleId><ArticleId IdType="pubmed">30992335</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K., Andersen P.M., Marklund S.L., Brannstrom T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2011;121:623&#x2013;634. doi: 10.1007/s00401-011-0805-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0805-3</ArticleId><ArticleId IdType="pmc">PMC3085063</ArticleId><ArticleId IdType="pubmed">21287393</ArticleId></ArticleIdList></Reference><Reference><Citation>Pare B., Lehmann M., Beaudin M., Nordstrom U., Saikali S., Julien J.P., Gilthorpe J.D., Marklund S.L., Cashman N.R., Andersen P.M., et al. Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis. Sci. Rep. 2018;8:14223. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Gravel M., Beland L.C., Soucy G., Abdelhamid E., Rahimian R., Gravel C., Kriz J. IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1. J. Neurosci. 2016;36:1031&#x2013;1048. doi: 10.1523/JNEUROSCI.0854-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0854-15.2016</ArticleId><ArticleId IdType="pmc">PMC6601999</ArticleId><ArticleId IdType="pubmed">26791230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Henkel J.S., Zhang W., Urushitani M., Julien J.P., Appel S.H. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia. 2010;58:231&#x2013;243. doi: 10.1002/glia.20919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20919</ArticleId><ArticleId IdType="pmc">PMC2784168</ArticleId><ArticleId IdType="pubmed">19672969</ArticleId></ArticleIdList></Reference><Reference><Citation>Epperly M.W., Fisher R., Rigatti L., Watkins S., Zhang X., Hou W., Shields D., Franicola D., Bayir H., Wang H., et al. Amelioration of Amyotrophic Lateral Sclerosis in SOD1(G93A) Mice by M2 Microglia from Transplanted Marrow. Vivo. 2019;33:675&#x2013;688. doi: 10.21873/invivo.11526.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.11526</ArticleId><ArticleId IdType="pmc">PMC6559904</ArticleId><ArticleId IdType="pubmed">31028184</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Z., Kuhn J.A., Wang X., Colquitt B., Solorzano C., Vaman S., Guan A.K., Evans-Reinsch Z., Braz J., Devor M., et al. Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain. Nat. Neurosci. 2016;19:94&#x2013;101. doi: 10.1038/nn.4189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4189</ArticleId><ArticleId IdType="pmc">PMC4703328</ArticleId><ArticleId IdType="pubmed">26642091</ArticleId></ArticleIdList></Reference><Reference><Citation>White F.A., Sun J., Waters S.M., Ma C., Ren D., Ripsch M., Steflik J., Cortright D.N., Lamotte R.H., Miller R.J. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc. Natl. Acad. Sci. USA. 2005;102:14092&#x2013;14097. doi: 10.1073/pnas.0503496102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0503496102</ArticleId><ArticleId IdType="pmc">PMC1236537</ArticleId><ArticleId IdType="pubmed">16174730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon M.J., Shin H.Y., Cui Y., Kim H., Thi A.H., Choi J.Y., Kim E.Y., Hwang D.H., Kim B.G. CCL2 Mediates Neuron-Macrophage Interactions to Drive Proregenerative Macrophage Activation Following Preconditioning Injury. J. Neurosci. 2015;35:15934&#x2013;15947. doi: 10.1523/JNEUROSCI.1924-15.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1924-15.2015</ArticleId><ArticleId IdType="pmc">PMC6605453</ArticleId><ArticleId IdType="pubmed">26631474</ArticleId></ArticleIdList></Reference><Reference><Citation>Szepesi Z., Manouchehrian O., Bachiller S., Deierborg T. Bidirectional Microglia-Neuron Communication in Health and Disease. Front. Cell. Neurosci. 2018;12:323. doi: 10.3389/fncel.2018.00323.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00323</ArticleId><ArticleId IdType="pmc">PMC6170615</ArticleId><ArticleId IdType="pubmed">30319362</ArticleId></ArticleIdList></Reference><Reference><Citation>Posfai B., Cserep C., Orsolits B., Denes A. New Insights into Microglia-Neuron Interactions: A Neuron&#x2019;s Perspective. Neuroscience. 2019;405:103&#x2013;117. doi: 10.1016/j.neuroscience.2018.04.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.04.046</ArticleId><ArticleId IdType="pubmed">29753862</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) J. Exp. Med. 1996;184:1101&#x2013;1109. doi: 10.1084/jem.184.3.1101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.184.3.1101</ArticleId><ArticleId IdType="pmc">PMC2192798</ArticleId><ArticleId IdType="pubmed">9064327</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucia M., Jankowski K., Reca R., Wysoczynski M., Bandura L., Allendorf D.J., Zhang J., Ratajczak J., Ratajczak M.Z. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J. Mol. Histol. 2004;35:233&#x2013;245. doi: 10.1023/B:HIJO.0000032355.66152.b8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:HIJO.0000032355.66152.b8</ArticleId><ArticleId IdType="pubmed">15339043</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinder A., Markhoff J., Jonitz-Heincke A., Sterna P., Salamon A., Bader R. Comparison of different cell culture plates for the enrichment of non-adherent human mononuclear cells. Exp. Med. 2019;17:2004&#x2013;2012. doi: 10.3892/etm.2019.7204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.7204</ArticleId><ArticleId IdType="pmc">PMC6395970</ArticleId><ArticleId IdType="pubmed">30867690</ArticleId></ArticleIdList></Reference><Reference><Citation>Jobe O., Kim J., Tycksen E., Onkar S., Michael N.L., Alving C.R., Rao M. Human Primary Macrophages Derived In Vitro from Circulating Monocytes Comprise Adherent and Non-Adherent Subsets with Differential Expression of Siglec-1 and CD4 and Permissiveness to HIV-1 Infection. Front. Immunol. 2017;8:1352. doi: 10.3389/fimmu.2017.01352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01352</ArticleId><ArticleId IdType="pmc">PMC5662875</ArticleId><ArticleId IdType="pubmed">29123518</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., King P.H., Si Y., Kwon Y., Varela V., Ibarburu S., Kovacs M., Moura I.C., Beckman J.S., Hermine O., et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. Jci Insight. 2018;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian F., Yang W., Mordes D.A., Wang J.Y., Salameh J.S., Mok J., Chew J., Sharma A., Leno-Duran E., Suzuki-Uematsu S., et al. Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging. Nat. Commun. 2016;7:13283. doi: 10.1038/ncomms13283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13283</ArticleId><ArticleId IdType="pmc">PMC5095598</ArticleId><ArticleId IdType="pubmed">27796305</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>